Pharmaceuticals | Free Full-Text | Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update | HTML
:%0A%0ABIIB094%20for%20Parkinson%20Disease.png?md=1 "BIIB094 for Parkinson Disease Clinical Trial 2022 | Power")
BIIB094 for Parkinson Disease Clinical Trial 2022 | Power
Parkinson's disease: major drug trial results to watch in 2022
![Top 10 Parkinson's Disease Clinical Trials [2022 Studies] | Power](https://pwr-og-img.withpower.com/Apply%20to%20this%20clinical%20trial%20treating%20Parkinson%20Disease,%20Parkinson's%20Disease%20(PD):%0A%0ADynamic%20cycling%20for%20Parkinson%20Disease.png?md=1 "Top 10 Parkinson's Disease Clinical Trials [2022 Studies] | Power")
Top 10 Parkinson's Disease Clinical Trials [2022 Studies] | Power
Home
Trends in clinical development for PD-1/PD-L1 inhibitors
Home
Agents in active PD drug trials, as of January 21, 2020 on... | Download Scientific Diagram
Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy - Annals of Oncology
First-in-class vaccine against IDO and PD-L1 enhances anti-PD-1 in phase I/II clinical trial
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies | SpringerLink
ScienceofParkinsons on Twitter: "The study explores data from 145 #Parkinsons clinical trials that were ongoing during 2019-2020, breaking them down into phase & agent type to give the PD community a broad
NIH launches partnership to improve success of clinical trials for patients with Parkinson's disease | National Institutes of Health (NIH)
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020 - IOS Press
International Parkinson's Disease Study (ROPAD): centogene.com
ScienceofParkinsons on Twitter: "Interesting analysis & discussion on clinical trial matters like enrollment, sponsors, trials sites, biomarkers, & geography. Plus what the category definition "disease modifying" actually means in #Parkinsons https://t ...
The Outlook Is Encouraging: Researchers Evaluate a Pipeline of Clinical Trials Targeting Parkinson's Disease | Journal of Parkinson's Disease
Trends in clinical development for PD-1/PD-L1 inhibitors
Clinical Trials 101 - Parkinson's Disease & Clinical Research
Parkinsonism & Related Disorders
AXO-Lenti-PD Gene Therapy Showing Benefits in 2nd Parkinson's Group
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020. - Abstract - Europe PMC
